Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
The survey was administered to infection control officers and laboratory personnel at 218 hospitals. The majority of respondents (91 percent) cite the need to optimize therapy away from broad spectrum agents, such as vancomycin, although 94 percent say that broad spectrum agents are often or sometimes used to treat infections.
More Articles on Patient Safety:
Surgery Centers Win AAAHC Institute Quality Improvement Award
8 Qualities of Forward-Thinking ASC Administrators
AAAHC Opens Public Comment Period for Proposed Changes to Accreditation Manual
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.